Table 2.
Whole Genome Sequencing predicted antibiotic susceptibility for 33 non-duplicate GBS isolates (See Supplemental Table 1 for MIC prediction values)
| Antibiotic | Targeted genes | Susceptible (%) | Non-Susceptible *(%) |
|---|---|---|---|
| Ampicillin | pbp2X | 33 (100) | - |
| Ceftriaxone | pbp2X | 33 (100) | - |
| Chloramphenicol | cat | 25 (75.6) | 8 (24.2) |
| Clindamycin | erm | 25 (75.6) | 8 (24.2) |
| Ceftaroline | pbp2X | 33 (100) | - |
| Erythromycin | erm or mef | 23 (69.7) | 10 (30.3) |
| Levofloxacin | parC, gyrA | 24 (72.7) | 9 (27.3) |
| Meropenem | pbp2X | 33 (100) | - |
| Linezolid | 23 S rRNA | 33 (100) | - |
| Penicillin | pbp2X | 33 (100) | - |
| Synercid** | erm + lsa | 33 (100) | - |
| Cefotaxime | pbp2X | 33 (100) | - |
| Tetracycline | tet | - | 33 (100) |
| Vancomycin | van | 33 (100) | - |
** Quinupristin/Dalfopristin
*Non-susceptibility includes both intermediate and resistant prediction